WORLD · VERIFIED DEVELOPMENT
India to Cap Trade Margins on Cancer Drugs, Targeting 70% Price Cuts
WHY IT MATTERS
By limiting trade margins, India could dramatically lower cancer drug costs, easing financial strain on patients and reducing overall healthcare expenditures.
What happened
The Indian government has announced a plan to cap trade margins on all types of cancer drugs at 30%. The move aims to make cancer medications more affordable and accessible, with experts estimating that prices could fall by up to 70%.
The policy is projected to generate annual savings of roughly Rs 2,500 crore for patients.
To determine which drugs will be covered, an expert committee will be convened to recommend a list of medicines subject to the margin cap.
PRIMARY SOURCES
Cancer drug prices may fall as government plans 30% trade margin cap
The Times of India · RUPALI MUKHERJEE · Discovery only; publisher copyright terms apply
CORRECTIONS & UPDATES
- Revision 1 · Initial ingestion · Oct 8, 2026, 9:45 PM
- Revision 2 · Source update detected · Oct 8, 2026, 9:45 PM